coverage from
i
What that date means
Coverage begins on 2026-08-10, which is when this archive started holding
Federal Register issues — not when the agency started publishing.
Anything earlier is absent from this page, and its absence is not evidence.
The Department of Health and Human Services published fifteen documents on August 12, 2026, comprising thirteen notices, one rule, and one proposed rule.
The Department of Health and Human Services published eight notices and one rule, including a final rule prohibiting Medicaid and CHIP funding for sex-rejecting procedures in individuals under 18 and 19, respectively.
Health and Human Services Department published nine notices, including determinations on drug withdrawals, a cooperative agreement award, guidance on container closure systems, and notices regarding user fees and data collections.
The Department of Health and Human Services published 17 documents on August 17, 2026, comprising 14 notices, two proposed rules, and one final rule.
The Food and Drug Administration published draft guidance on abbreviated drug application pathways and announced a public workshop on testosterone use in menopausal women.
The Food and Drug Administration published three proposed rules on color additive petitions and one final rule permitting chromium DL-methionine chelate in animal feed.
The Health and Human Services Department published thirteen notices on August 20, 2026, including paperwork reduction act reviews, advisory committee renewals, and guidance documents.
The Health and Human Services Department published seven notices on August 21, 2026, including information collection requests and a government-owned invention available for license.
The Department of Health and Human Services published five notices on August 25, 2026, including a request for information on emerging science relevant to the National Institute on Deafness and Other Communication Disorders' strategic plan.
The Health and Human Services Department published eight notices on August 27, 2026, including closed meeting notices, a drug efficacy study implementation extension, and cooperative agreement awards.
The Department of Health and Human Services published ten notices and one rule on August 28, 2026, including corrections to federal independent dispute resolution operations and multiple information collection requests.
The Health and Human Services Department published ten notices on August 31, 2026, including authorizations for emergency use of animal drugs for New World screwworm treatment.
The Department of Health and Human Services published ten notices, including meeting notices for multiple institutes, an information collection request comment period closing November 2, and a list of certified drug testing laboratories.
The Department of Health and Human Services published twelve notices in the Federal Register on September 2, 2026.
The Department of Health and Human Services published four notices including an information collection request, a drug withdrawal determination, an emergency use authorization declaration, and a meeting notice.
The Department of Health and Human Services published six notices on September 8, 2026, including information collection requests and a Medicare town hall meeting announcement.
The Food and Drug Administration published guidance on temporary policies for compounding starter parenteral nutrition drug products for neonates.
The Food and Drug Administration published eight medical device classifications, one food additive petition withdrawal, one priority review voucher fee notice, and three funding or programmatic notices.
The Food and Drug Administration classified cardiovascular machine learning-based notification software as class II medical devices, effective September 11, 2026.
- Notice National Heart, Lung, and Blood Institute; Notice of Meeting↗ 2026-18615
- Rule Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software↗ 2026-18612
- Notice Agency Information Collection Activities: Submission for OMB Review; Comment Request↗ 2026-18611
- Notice Notice of Supplemental Funding, Appalachian Region Healthcare Support Program↗ 2026-18570
- Notice Notice of Supplemental Funding, Infant-Toddler Court Program-State Awards↗ 2026-18568
- Notice Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Health Network Development Program Performance Improvement and Measurement System, OMB No. 0906-0010-Revision↗ 2026-18553
- Notice Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate↗ 2026-18551
- Notice Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Tracking↗ 2026-18529
- Notice Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for Qualitative Data To Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed↗ 2026-18528
- Notice Notice of Supplemental Funding, Rural Hospital Stabilization Pilot Program↗ 2026-18518
- Notice National Institute on Aging; Amended Notice of Meeting↗ 2026-18514
- Notice National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting↗ 2026-18513
- Notice Center for Scientific Review; Notice of Closed Meetings↗ 2026-18512
The Health and Human Services Department published ten notices on September 14, 2026, including paperwork reduction act reviews, advisory council nomination solicitations, and information collection proposals.
The Health and Human Services Department published 13 notices on September 16, 2026, including Medicare appeals threshold adjustments, HCPCS coding meetings, and research integrity procedures.
The Food and Drug Administration published final guidance on blood collection, processing, and storage systems using the buffy coat method for blood component manufacture.
The Health and Human Services Department published 17 notices on September 18, 2026, including vaccine injury compensation petitions, medical device submission guidance, and supplemental funding awards.
The Food and Drug Administration published thirteen notices on information collection activities, program announcements, and supplemental funding awards.
The Department of Health and Human Services published an interim final rule establishing temporary authority to pause agent and broker registration for Federally-facilitated Exchanges.
The Department of Health and Human Services published four notices and one proposed rule on September 24, 2026.
The Department of Health and Human Services published eight notices, one proposed rule, and one final rule on September 25, 2026.
The Department of Health and Human Services published nine notices, including submissions to the Office of Management and Budget for information collection review and notices of data collection proposals and closed meetings.
The Department of Health and Human Services published a corrected rule on Medicare hospital payment systems for fiscal year 2027 and nine notices on various matters.
The Health and Human Services Department published notices on closed meetings, an information collection request, and a correction regarding withdrawn drug applications.
The Indian Health Service published two final rules removing obsolete and suspended regulations from the Code of Federal Regulations.
The Food and Drug Administration published 20 documents including three device classifications, notices of drug application withdrawals and approvals, and information collection requests.
- Notice Center for Scientific Review; Notice of Closed Meetings↗ 2026-20771
- Notice Center For Scientific Review; Notice of Closed Meetings↗ 2026-20770
- Notice Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZANVASTRO (Zilganersen)↗ 2026-20769
- Notice Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements↗ 2026-20768
- Notice Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC↗ 2026-20766
- Notice Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use↗ 2026-20765
- Notice Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness↗ 2026-20764
- Notice Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications↗ 2026-20762
- Notice Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams↗ 2026-20758
- Notice Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Data System for Organ Procurement and Transplantation Network, OMB No. 0906-0110-Revision↗ 2026-20732
- Notice Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Applicant Organizational National Provider Identifiers and Centers for Medicare & Medicaid Services Certification Numbers Form↗ 2026-20731
- Notice Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction↗ 2026-20730
- Rule Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens↗ 2026-20727
- Rule Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use↗ 2026-20726
- Rule Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit↗ 2026-20725
- Notice Agency Information Collection Activities: Proposed Collection; Comment Request↗ 2026-20723
- Proposed Rule Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability↗ 2026-20721
- Notice Challenges and Solutions in Lot-Level Food Traceability; Public Meeting↗ 2026-20720
- Notice National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting↗ 2026-20719
- Notice Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof↗ 2026-20705
The Health and Human Services Department published six documents, including a final rule permitting salt substitutes in standardized foods effective December 14, 2026.
The Health and Human Services Department published 15 documents on October 14, 2026, comprising 13 notices, one proposed rule, and one final rule.
The Health and Human Services Department published six notices on October 15, 2026, including emergency use authorizations for four animal drugs to prevent and treat New World screwworm infestations.
The Department of Health and Human Services published thirteen notices on October 16, 2026, including meeting announcements and information collection requests.
Ask an assistant instead
Everything on this page is also a tool call. Add
mcp.downstream.sh as an MCP server in Claude, ChatGPT, or any client that speaks the
protocol — no key, no account — then paste this:
Using the Downstream MCP server at mcp.downstream.sh, call whats_new_since with agency "Health and Human Services Department" since 2026-08-10, then tell me what this agency has been working on and which of its deadlines are still open.
Reaches whats_new_since. The response carries its own citations
and states what it is missing — including which dates it has no record for.